35 results on '"Nardo, Mirella"'
Search Results
2. Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
3. The role of obesity on outcomes of adoptive cellular therapy in solid tumors.
4. Clinical and genomic landscape of RAS mutations in gynecologic cancers
5. Phase 1 Clinical Trials: Challenges and Opportunities in Latin America
6. Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors
7. Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma
8. Genetic Predisposition and Hereditary Syndromes
9. Learning From Failure: Negative Trials in Oncology
10. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience
11. Adoptive Cell Therapy in Gynecologic Cancers: A Systematic Review and Meta-analysis
12. Safety and efficacy of immune checkpoint inhibitors in patients with cancer and viral hepatitis: The MD Anderson Cancer Center experience
13. Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis (309)
14. Preoperative variables associated with transfusion requirements in orthotopic liver transplantation
15. Abstract 2764: Safety and efficacy of CAR T and TCR therapies in solid tumors: A systematic review and meta-analysis, including a comparison with five phase II trials in hematologic malignancies used for the first FDA approvals of these agents
16. Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience
17. Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
18. Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil
19. CA209-9JC: A phase II study of first-line nivolumab (NIVO) in patients (pts) with locally advanced or metastatic cutaneous squamous cell carcinoma.
20. Metformina para a quimioprofilaxia do câncer: uma revisão sistemática atualizada sobre o papel da metformina na prevenção do câncer.
21. RELAÇÃO NEUTRÓFILO-LINFÓCITO E RELAÇÃO PLAQUETA-LINFÓCITO COMO FATORES PROGNÓSTICOS EM PACIENTES COM CARCINOMA RENAL METASTÁTICO DE HISTOLOGIA NÃO CÉLULAS CLARAS OU SARCOMATOIDE
22. Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum
23. Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian Population
24. DADOS DA VIDA REAL DA EFICÁCIA E SEGURANÇA DE SUNITINIBE E PAZOPANIBE EM PRIMEIRA LINHA NO CARCINOMA RENAL DE CÉLULAS CLARAS METASTÁTICO: EXPERIÊNCIA DE CENTRO ÚNICO NO BRASIL
25. Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers
26. Predictors of survival outcomes in patients (pts) with advanced solid tumors treated with cellular therapies in early clinical trials.
27. Clinical and genomic landscape of RAS pathway mutations in gynecologic cancers.
28. RAF-inhibitor rechallenge therapy in BRAF aberrated pan-cancers: RE-RAFFLE study.
29. Intrapatient comparative efficacy of selective RET inhibitors using growth modulation index in patients with RET aberrant cancers.
30. Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial.
31. Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian Population.
32. Cannabidiol reverses the mCPP‐induced increase in marble‐burying behavior
33. Hemoglobin concentration increment is associated with a better prognosis in HIV patients with anemia
34. Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
35. Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.